Objective and subjective measures of dalfampridine efficacy in clinical practice.
Sylvia KlineovaRebecca FarberJoshua FriedmanColleen FarrellFred D LublinStephen KriegerPublished in: Multiple sclerosis journal - experimental, translational and clinical (2018)
Our results suggest that T25FW alone might not be sufficient for response characterization and that adding patient-reported measures may further elucidate the therapeutic response.